Inhibition of HPV-16 E7 oncogenic activity by HPV-16 E2

被引:0
|
作者
N Gammoh
E Isaacson
V Tomaić
D J Jackson
J Doorbar
L Banks
机构
[1] International Centre for Genetic Engineering and Biotechnology,Division of Virology
[2] MRC National Institute for Medical Research,undefined
来源
Oncogene | 2009年 / 28卷
关键词
HPV; E7; centrosomes; pRb;
D O I
暂无
中图分类号
学科分类号
摘要
Human papillomavirus (HPV) E7 is essential in inducing S-phase progression in differentiating epithelial cells. We have previously shown that HPV-16 E7 activity can be controlled by a direct interaction with the viral transcriptional activator E2, thereby inhibiting transforming potential of E7. We have extended these analyses to show that E2 induces a generalized re-localization of E7 within the cell nucleus, one potential consequence of which is the inhibition of E7-induced degradation of pRb. Most importantly, we show that E2 can also inhibit the ability of E7 to induce centrosome abnormalities, thus preventing aberrant mitoses. Taken together, these studies highlight the central importance of E2 in controlling the functions of E7, independently of the ability of E2 to regulate transcription.
引用
收藏
页码:2299 / 2304
页数:5
相关论文
共 50 条
  • [41] Identification and characterisation of novel potential phospho-acceptor sites in HPV-16 E7
    Trejo-Cerro, Oscar
    Broniarczyk, Justyna
    Kavcic, Nezka
    Myers, Michael
    Banks, Lawrence
    [J]. TUMOUR VIRUS RESEARCH, 2023, 16
  • [42] Mice immunization with live lactococci displaying a surface anchored HPV-16 E7 oncoprotein
    Cortes-Perez, NG
    Bermúdez-Humarán, LG
    Le Loir, Y
    Rodriguez-Padilla, C
    Gruss, A
    Saucedo-Cárdenas, O
    Langella, P
    Montes-de-Oca-Luna, R
    [J]. FEMS MICROBIOLOGY LETTERS, 2003, 229 (01) : 37 - 42
  • [43] The HPV-16 E7 oncogene sensitizes malignant cells to IFN-α-induced apoptosis
    Thyrell, L
    Sangfelt, O
    Zhivotovsky, B
    Pokrovskaja, K
    Wang, YS
    Einhorn, S
    Grandér, D
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2005, 25 (02): : 63 - 72
  • [44] HPV-16 E6 and E7 oncogene expression is downregulated as a result of Mdm2 knockdown
    Diaz, Daniel
    Salinas Santander, Mauricio A.
    Morlett Chavez, Jesus A.
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 41 (01) : 141 - 146
  • [45] SCANNING THE STRUCTURE AND ANTIGENICITY OF HPV-16 E6 AND E7 ONCOPROTEINS USING ANTIPEPTIDE ANTIBODIES
    STACEY, SN
    EKLUND, C
    JORDAN, D
    SMITH, NK
    STERN, PL
    DILLNER, J
    ARRAND, JR
    [J]. ONCOGENE, 1994, 9 (02) : 635 - 645
  • [46] Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccines
    Chen, CH
    Wang, TL
    Hung, CF
    Pardoll, DM
    Wu, TC
    [J]. VACCINE, 2000, 18 (19) : 2015 - 2022
  • [47] Interaction between the HPV-16 E2 transcriptional activator and p53
    Paola Massimi
    David Pim
    Cosetta Bertoli
    Véronique Bouvard
    Lawrence Banks
    [J]. Oncogene, 1999, 18 : 7748 - 7754
  • [48] HPV-16 E7 Interacts with the Endocytic Machinery via the AP2 Adaptor μ2 Subunit
    Basukala, Om
    Trejo-Cerro, Oscar
    Myers, Michael P.
    Pim, David
    Massimi, Paola
    Thomas, Miranda
    Guarnaccia, Corrado
    Owen, David
    Banks, Lawrence
    [J]. MBIO, 2022, 13 (06):
  • [49] Role of AP-1 and C/EBP in regulation of HPV-16 E6/E7 promoter activity
    Chen, Z
    Lui, Y
    Ji, JZ
    Yuan, XH
    Clayman, GL
    Adler-Storthz, K
    [J]. FASEB JOURNAL, 2000, 14 (08): : A1442 - +
  • [50] Interaction between the HPV-16 E2 transcriptional activator and p53
    Massimi, P
    Pim, D
    Bertoli, C
    Bouvard, V
    Banks, L
    [J]. ONCOGENE, 1999, 18 (54) : 7748 - 7754